FDA granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
